- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT07584798
Self-Monitoring OCT
7. maj 2026 opdateret af: Warren Sobol, Case Western Reserve University
Self-Monitoring Optical Coherence Tomography Device for Retinal Telehealth
The purpose of this research study is to test participants ability to obtain OCT images of the eyes using an OCT device that is comparable to FDA-approved OCT devices on the market, without the help of an eye technician.
Patients with ocular diseases often need to come to frequent appointments with an eye care provider for close monitoring and evaluation.
Transportation difficulties, other medical problems, and limited appointments slots can make regular follow-up challenging.
In addition, the anxiety of permanent vision loss and subjective nature of monitoring symptoms highlight the need for an alternative solution in which patients can self-generate OCT images of the eye for the eye care provider to review.
Studieoversigt
Status
Ikke rekrutterer endnu
Intervention / Behandling
Undersøgelsestype
Interventionel
Tilmelding (Anslået)
100
Fase
- Ikke anvendelig
Kontakter og lokationer
Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.
Studiesteder
-
-
Ohio
-
Cleveland, Ohio, Forenede Stater, 44106
- University Hospitals Cleveland Medical Center
-
Ledende efterforsker:
- Warren Sobol, MD
-
-
Deltagelseskriterier
Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.
Berettigelseskriterier
Aldre berettiget til at studere
- Voksen
- Ældre voksen
Tager imod sunde frivillige
Ja
Beskrivelse
Inclusion Criteria:
- 1. Provision of signed and dated informed consent.
- 2. Age ≥ 18 years.
- 3. Presenting for care at a University Hospitals Eye Institute clinic
- 4. Willing to complete study questionnaires.
- 5. Scheduled to undergo standard technician-acquired OCT
Exclusion Criteria:
- 1. Unable to provide informed consent or, in the judgment of study staff, unable to understand study procedures.
- 2. Unable to cooperate with imaging or maintain stable positioning such that an evaluable OCT scan cannot be obtained (e.g., severe tremor or inability to maintain head position).
- 3. Facial skin condition or open wound at the points of device contact that would make use of the headrest unsafe.
- 4. Acute medical or ocular condition requiring immediate evaluation that, in the PI's judgment, precludes participation at that time.
- 5. Any other condition that, in the opinion of the PI/designee, would place the participant at undue risk or compromise data quality (documented).
- 6. Patients with visual acuity <20/200.
- 7. Patients with significant media opacities precluding an OCT scan (posterior subcapsular cataract, vitreous hemorrhage, etc), or severe ptosis.
Studieplan
Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Sundhedstjenesteforskning
- Tildeling: Ikke-randomiseret
- Interventionel model: Parallel tildeling
- Maskning: Enkelt
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
|---|---|
|
Eksperimentel: Self-administered OCT Images
Participants will use an OCT device to obtain OCT images of the eyes.
|
Self-administered OCT imaging using modified portable OCT with headrest and software workflow to enable patient self-operation and secure image transfer to a remote reading center.
|
|
Aktiv komparator: Technician-acquired OCT
Technicians will use a standard OCT device to obtain OCT images of the eyes as per standard of care.
|
Technician-acquired OCT obtained using routine clinical equipment during the same visit
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Tidsramme |
|---|---|
|
Number of inner retinal abnormalities detected as measured by OCT images
Tidsramme: Up to 60 minutes
|
Up to 60 minutes
|
|
Number of outer retinal abnormalities detected as measured by OCT images.
Tidsramme: Up to 60 minutes
|
Up to 60 minutes
|
|
Sensitivity as measured by OCT images.
Tidsramme: Up to 60 mins
|
Up to 60 mins
|
|
Specificity as measured by OCT images.
Tidsramme: Up to 60 mins
|
Up to 60 mins
|
|
Positive predictive value (PPV) as measured by OCT images.
Tidsramme: Up to 60 mins
|
Up to 60 mins
|
|
Negative predictive value (NPV) as measured by OCT images.
Tidsramme: Up to 60 mins
|
Up to 60 mins
|
Sekundære resultatmål
Resultatmål |
Tidsramme |
|---|---|
|
Image-quality as recorded by nurse coordinator during patient interaction with the device.
Tidsramme: Up to 60 mins
|
Up to 60 mins
|
|
Number of successful completion of self-scans as recorded by nurse coordinator during patient interaction with the device.
Tidsramme: Up to 60 mins
|
Up to 60 mins
|
|
Number of repeated attempts
Tidsramme: Up to 60 mins
|
Up to 60 mins
|
Samarbejdspartnere og efterforskere
Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.
Sponsor
Efterforskere
- Ledende efterforsker: Warren Sobol, MD, University Hospitals Cleveland Medical Center
Datoer for undersøgelser
Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.
Studer store datoer
Studiestart (Anslået)
1. juli 2026
Primær færdiggørelse (Anslået)
15. december 2027
Studieafslutning (Anslået)
15. december 2027
Datoer for studieregistrering
Først indsendt
7. maj 2026
Først indsendt, der opfyldte QC-kriterier
7. maj 2026
Først opslået (Faktiske)
13. maj 2026
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
13. maj 2026
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
7. maj 2026
Sidst verificeret
1. maj 2026
Mere information
Begreber relateret til denne undersøgelse
Nøgleord
Andre undersøgelses-id-numre
- STUDY20211004
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
INGEN
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Ingen
Studerer et amerikansk FDA-reguleret enhedsprodukt
Ingen
produkt fremstillet i og eksporteret fra U.S.A.
Ingen
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .
Kliniske forsøg med Self-administered OCT imaging system
-
Gentuity, LLCRekruttering
-
Duke UniversityRekrutteringGrøn stær | Synsnervesygdomme | NethindesygdomForenede Stater
-
International Spine Study Group FoundationDePuy SynthesAktiv, ikke rekrutterendeCervikal deformitetForenede Stater
-
University College DublinMater Misericordiae University HospitalRekrutteringCervikal ustabilitet Rygsøjlen | Rygrad; UstabilitetIrland
-
Gentuity, LLCAfsluttet
-
Medicrea InternationalAfsluttetSpinal stenose | Spinalfrakturer | Spondylolistese | Spinale neoplasmer | Intervertebral disc sygdomFrankrig
-
Johannes Kepler University of LinzRekrutteringMakuladegeneration | Diabetisk retinopati | NethindesygdomØstrig
-
Memorial Sloan Kettering Cancer CenterAfsluttetBasal blodgennemstrømningForenede Stater
-
Mayo ClinicAmerican Society for Gastrointestinal EndoscopyTrukket tilbage
-
National Eye Institute (NEI)AfsluttetMakuladegeneration | Diabetisk retinopati | Mitokondrier | Hippel-Landaus sygdomForenede Stater